← Eichor
Study identifier: NCT07280091 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Study of Skin and Gut Microbiome in a Skin Condition Involving Skin Barrier Impairment and Allergic Symptoms: Netherton Syndrome

Condition: Netherton Syndrome  ·  Sponsor: Assistance Publique - Hôpitaux de Paris

PhaseN/A
Planned participants30
Who can joinAll sexes, 10 Years to no upper limit
Healthy volunteersNo

About this study

It is proposed to conduct an exploratory study to analyze the skin, intestinal, and salivary microbiome, as well as the skin mycobiome and virome, of patients (adolescents and young adults) with Netherton syndrome, a condition characterized by an impaired skin barrier that most likely promotes the development of allergic manifestations. The study will be conducted on patients with Netherton syndrome and control subjects in order to investigate possible correlation factors between the three microbiomes and identify which ones.

This description comes directly from the study's public registry record.

Talk to the study team

Christine BODEMER, PhD  ·  01 44 49 46 72  ·  christine.bodemer@aphp.fr

Victor BRUYERE, MSc  ·  01 34 29 23 24  ·  victor.bruyere@aphp.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Hôpital Necker Enfants MaladesParis, Île-de-France Region, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07280091